PD-L1 Inhibitors Market, Global Outlook and Forecast 2022-2028

February 2022 | 76 pages | ID: P503B775440EEN
Market Monitor Global

Abstracts

PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs

This report contains market size and forecasts of PD-L1 Inhibitors in global, including the following market information:

Global PD-L1 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global PD-L1 Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five PD-L1 Inhibitors companies in 2021 (%)

The global PD-L1 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

TECENTRIQ Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of PD-L1 Inhibitors include Roche, AstraZeneca and Merck KGaA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global PD-L1 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global PD-L1 Inhibitors Market Segment Percentages, by Type, 2021 (%)

• TECENTRIQ
• Imfinzi
• Bavencio

Global PD-L1 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global PD-L1 Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacy
• Hospital Pharmacy
• Other

Global PD-L1 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global PD-L1 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies PD-L1 Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies PD-L1 Inhibitors revenues share in global market, 2021 (%)

Key companies PD-L1 Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)

Key companies PD-L1 Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• AstraZeneca
• Merck KGaA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 PD-L1 Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global PD-L1 Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PD-L1 INHIBITORS OVERALL MARKET SIZE

2.1 Global PD-L1 Inhibitors Market Size: 2021 VS 2028
2.2 Global PD-L1 Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PD-L1 Inhibitors Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top PD-L1 Inhibitors Players in Global Market
3.2 Top Global PD-L1 Inhibitors Companies Ranked by Revenue
3.3 Global PD-L1 Inhibitors Revenue by Companies
3.4 Global PD-L1 Inhibitors Sales by Companies
3.5 Global PD-L1 Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PD-L1 Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PD-L1 Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 PD-L1 Inhibitors Players in Global Market
  3.8.1 List of Global Tier 1 PD-L1 Inhibitors Companies
  3.8.2 List of Global Tier 2 and Tier 3 PD-L1 Inhibitors Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global PD-L1 Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 TECENTRIQ
  4.1.3 Imfinzi
  4.1.4 Bavencio
4.2 By Type - Global PD-L1 Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global PD-L1 Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global PD-L1 Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global PD-L1 Inhibitors Sales & Forecasts
  4.3.1 By Type - Global PD-L1 Inhibitors Sales, 2017-2022
  4.3.2 By Type - Global PD-L1 Inhibitors Sales, 2023-2028
  4.3.3 By Type - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global PD-L1 Inhibitors Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global PD-L1 Inhibitors Market Size, 2021 & 2028
  5.1.2 Retail Pharmacy
  5.1.3 Hospital Pharmacy
  5.1.4 Other
5.2 By Application - Global PD-L1 Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global PD-L1 Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global PD-L1 Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global PD-L1 Inhibitors Sales & Forecasts
  5.3.1 By Application - Global PD-L1 Inhibitors Sales, 2017-2022
  5.3.2 By Application - Global PD-L1 Inhibitors Sales, 2023-2028
  5.3.3 By Application - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global PD-L1 Inhibitors Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global PD-L1 Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global PD-L1 Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global PD-L1 Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global PD-L1 Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global PD-L1 Inhibitors Sales & Forecasts
  6.3.1 By Region - Global PD-L1 Inhibitors Sales, 2017-2022
  6.3.2 By Region - Global PD-L1 Inhibitors Sales, 2023-2028
  6.3.3 By Region - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America PD-L1 Inhibitors Revenue, 2017-2028
  6.4.2 By Country - North America PD-L1 Inhibitors Sales, 2017-2028
  6.4.3 US PD-L1 Inhibitors Market Size, 2017-2028
  6.4.4 Canada PD-L1 Inhibitors Market Size, 2017-2028
  6.4.5 Mexico PD-L1 Inhibitors Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe PD-L1 Inhibitors Revenue, 2017-2028
  6.5.2 By Country - Europe PD-L1 Inhibitors Sales, 2017-2028
  6.5.3 Germany PD-L1 Inhibitors Market Size, 2017-2028
  6.5.4 France PD-L1 Inhibitors Market Size, 2017-2028
  6.5.5 U.K. PD-L1 Inhibitors Market Size, 2017-2028
  6.5.6 Italy PD-L1 Inhibitors Market Size, 2017-2028
  6.5.7 Russia PD-L1 Inhibitors Market Size, 2017-2028
  6.5.8 Nordic Countries PD-L1 Inhibitors Market Size, 2017-2028
  6.5.9 Benelux PD-L1 Inhibitors Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia PD-L1 Inhibitors Revenue, 2017-2028
  6.6.2 By Region - Asia PD-L1 Inhibitors Sales, 2017-2028
  6.6.3 China PD-L1 Inhibitors Market Size, 2017-2028
  6.6.4 Japan PD-L1 Inhibitors Market Size, 2017-2028
  6.6.5 South Korea PD-L1 Inhibitors Market Size, 2017-2028
  6.6.6 Southeast Asia PD-L1 Inhibitors Market Size, 2017-2028
  6.6.7 India PD-L1 Inhibitors Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America PD-L1 Inhibitors Revenue, 2017-2028
  6.7.2 By Country - South America PD-L1 Inhibitors Sales, 2017-2028
  6.7.3 Brazil PD-L1 Inhibitors Market Size, 2017-2028
  6.7.4 Argentina PD-L1 Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa PD-L1 Inhibitors Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa PD-L1 Inhibitors Sales, 2017-2028
  6.8.3 Turkey PD-L1 Inhibitors Market Size, 2017-2028
  6.8.4 Israel PD-L1 Inhibitors Market Size, 2017-2028
  6.8.5 Saudi Arabia PD-L1 Inhibitors Market Size, 2017-2028
  6.8.6 UAE PD-L1 Inhibitors Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche PD-L1 Inhibitors Major Product Offerings
  7.1.4 Roche PD-L1 Inhibitors Sales and Revenue in Global (2017-2022)
  7.1.5 Roche Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca PD-L1 Inhibitors Major Product Offerings
  7.2.4 AstraZeneca PD-L1 Inhibitors Sales and Revenue in Global (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Merck KGaA
  7.3.1 Merck KGaA Corporate Summary
  7.3.2 Merck KGaA Business Overview
  7.3.3 Merck KGaA PD-L1 Inhibitors Major Product Offerings
  7.3.4 Merck KGaA PD-L1 Inhibitors Sales and Revenue in Global (2017-2022)
  7.3.5 Merck KGaA Key News

8 GLOBAL PD-L1 INHIBITORS PRODUCTION CAPACITY, ANALYSIS

8.1 Global PD-L1 Inhibitors Production Capacity, 2017-2028
8.2 PD-L1 Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global PD-L1 Inhibitors Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PD-L1 INHIBITORS SUPPLY CHAIN ANALYSIS

10.1 PD-L1 Inhibitors Industry Value Chain
10.2 PD-L1 Inhibitors Upstream Market
10.3 PD-L1 Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 PD-L1 Inhibitors Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of PD-L1 Inhibitors in Global Market
Table 2. Top PD-L1 Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PD-L1 Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PD-L1 Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global PD-L1 Inhibitors Sales by Companies, (K Units), 2017-2022
Table 6. Global PD-L1 Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PD-L1 Inhibitors Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers PD-L1 Inhibitors Product Type
Table 9. List of Global Tier 1 PD-L1 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-L1 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PD-L1 Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PD-L1 Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PD-L1 Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PD-L1 Inhibitors Sales (K Units), 2017-2022
Table 15. By Type - Global PD-L1 Inhibitors Sales (K Units), 2023-2028
Table 16. By Application – Global PD-L1 Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PD-L1 Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PD-L1 Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PD-L1 Inhibitors Sales (K Units), 2017-2022
Table 20. By Application - Global PD-L1 Inhibitors Sales (K Units), 2023-2028
Table 21. By Region – Global PD-L1 Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PD-L1 Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PD-L1 Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PD-L1 Inhibitors Sales (K Units), 2017-2022
Table 25. By Region - Global PD-L1 Inhibitors Sales (K Units), 2023-2028
Table 26. By Country - North America PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PD-L1 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PD-L1 Inhibitors Sales, (K Units), 2017-2022
Table 29. By Country - North America PD-L1 Inhibitors Sales, (K Units), 2023-2028
Table 30. By Country - Europe PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PD-L1 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PD-L1 Inhibitors Sales, (K Units), 2017-2022
Table 33. By Country - Europe PD-L1 Inhibitors Sales, (K Units), 2023-2028
Table 34. By Region - Asia PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PD-L1 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PD-L1 Inhibitors Sales, (K Units), 2017-2022
Table 37. By Region - Asia PD-L1 Inhibitors Sales, (K Units), 2023-2028
Table 38. By Country - South America PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PD-L1 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PD-L1 Inhibitors Sales, (K Units), 2017-2022
Table 41. By Country - South America PD-L1 Inhibitors Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PD-L1 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PD-L1 Inhibitors Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa PD-L1 Inhibitors Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche PD-L1 Inhibitors Product Offerings
Table 48. Roche PD-L1 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca PD-L1 Inhibitors Product Offerings
Table 51. AstraZeneca PD-L1 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck KGaA Corporate Summary
Table 53. Merck KGaA PD-L1 Inhibitors Product Offerings
Table 54. Merck KGaA PD-L1 Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. PD-L1 Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 56. Global PD-L1 Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 57. Global PD-L1 Inhibitors Production by Region, 2017-2022 (K Units)
Table 58. Global PD-L1 Inhibitors Production by Region, 2023-2028 (K Units)
Table 59. PD-L1 Inhibitors Market Opportunities & Trends in Global Market
Table 60. PD-L1 Inhibitors Market Drivers in Global Market
Table 61. PD-L1 Inhibitors Market Restraints in Global Market
Table 62. PD-L1 Inhibitors Raw Materials
Table 63. PD-L1 Inhibitors Raw Materials Suppliers in Global Market
Table 64. Typical PD-L1 Inhibitors Downstream
Table 65. PD-L1 Inhibitors Downstream Clients in Global Market
Table 66. PD-L1 Inhibitors Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. PD-L1 Inhibitors Segment by Type
Figure 2. PD-L1 Inhibitors Segment by Application
Figure 3. Global PD-L1 Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PD-L1 Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PD-L1 Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. PD-L1 Inhibitors Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PD-L1 Inhibitors Revenue in 2021
Figure 9. By Type - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global PD-L1 Inhibitors Price (US$/Unit), 2017-2028
Figure 12. By Application - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global PD-L1 Inhibitors Price (US$/Unit), 2017-2028
Figure 15. By Region - Global PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 19. US PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 33. China PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PD-L1 Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PD-L1 Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PD-L1 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global PD-L1 Inhibitors Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production PD-L1 Inhibitors by Region, 2021 VS 2028
Figure 50. PD-L1 Inhibitors Industry Value Chain
Figure 51. Marketing Channels